pSivida Corp. Announces Fourth Quarter and Fiscal Year 2016

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
pSivida Corp. Announces Fourth Quarter and Fiscal Year 2016 Financial Results Release Date and Conference Call Information

WATERTOWN, Mass., Sept. 01, 2016 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ: PSDV ) (ASX:PVA), a leader in the development of sustained release drug delivery products primarily for treating eye diseases, today announced its financial results for the fourth quarter and fiscal year 2016 will be released after the market close on Monday, September 12, 2016, followed the same day by a conference call and live webcast scheduled for 4:30 p.m. ET.

The conference call may be accessed by dialing (877) 312-7507 from the U.S. and Canada, or (631) 813-4828 from international locations. The conference ID is 71781786. A live webcast will be available on the Investor Relations section of the corporate website at http://www.psivida.com .

A replay of the call will be available beginning September 12, 2016, at approximately 7:30 p.m. ET and ending on September 19, 2016, at 11:59 p.m. ET. The replay may be accessed by dialing (855) 859-2056 within the U.S. and Canada or (404) 537-3406 from international locations, Conference ID Number: 71781786. A replay of the webcast will also be available on the corporate website during that time.

About pSivida Corp.  pSivida Corp. ( www.psivida.com ), headquartered in Watertown, MA, is a leader in the development of sustained release, drug delivery products for treating eye diseases. pSivida has developed three of only four FDA-approved sustained-release treatments for back-of-the-eye diseases. The most recent, ILUVIEN®, a micro-insert for diabetic macular edema, licensed to Alimera Sciences, is currently sold in the U.S. and three EU countries. Retisert®, an implant for posterior uveitis, is licensed to and sold by Bausch & Lomb. pSivida’s lead product candidate, Medidur™, a micro-insert for posterior uveitis being independently developed, is currently in pivotal Phase 3 clinical trials, with an NDA anticipated in 2017. pSivida’s pre-clinical development program is focused on using its core platform technologies Durasert™ and Tethadur™ to deliver drugs and biologics to treat wet and dry age-related macular degeneration, glaucoma, osteoarthritis and other diseases. To learn more about pSivida please visit www.psivida.com and connect on Twitter , LinkedIn , Facebook and Google+ .

Contact: Beverly Jedynak T:         312-943-1123 M:        773-350-5793 blj@bevlynconsulting.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Humberto Quintanar Strengthens McKinley Irvin's Seattle Team

Updated Category News Views 46

Humberto Quintanar Makes His Move In a world where legal battles can shake lives to the core, McKinley Irvin is throwing another heavyweight into the ring. They’ve just pulled in Humberto Quintanar, a guy who knows his way around a courtroom like a cabbie knows a city's backstreets. This isn't just another seat-fillin' lawyer; Quintanar packs years of experience as a...

Continue Reading
Approved Oil Secures Long-Term NYC Fuel Terminal Deal

Updated Category News Views 94

Approved Oil Locks in Future with Sunoco Deal Amidst the contraction of New York City's fuel terminal landscape, securing a consistent lifeline to crucial infrastructure feels like striking gold. Approved Oil just locked down an agreement with Sunoco for a new terminal location that'll last deep into the 2040s, and it's about more than just securing a spot on the...

Continue Reading
Columbia Distributing Expands to Alaska: A Growth Move

Updated Category News Views 33

Alaska's Entry: Columbia's New Frontier When Columbia Distributing dives into a new territory, you know they're serious about growth. This latest move sees them planting their flag in Alaska, finally completing a strategic vision that's been brewing for a while. Four-State Strategy Comes to Fruition The transaction with Republic National Distributing Company (RNDC) is no...

Continue Reading
Gildan's Troubling Legal Struggles: Investor Action Alert

Updated Category News Views 60

Gildan's Bumpy Ride: Legal Woes Unfold Well, folks, seems like Gildan Activewear Inc. (NYSE:GIL) is in for a bumpy ride, and not the kind that makes you feel alive, I tell ya. They've been slapped with a class action lawsuit, and the news ain't pretty. Accusations are flying hot about how they've been playing fast and loose with their financials. The Allegations: Channel...

Continue Reading
DropGenie Nets $5M to Boost Functional Biology Reach

Updated Category News Views 109

DropGenie Scores Big with Fresh Financing Boost Out of the Montreal wilderness, DropGenie is charging forward with a fresh $5 million injection in Seed+ financing. This isn't just loose change; it's a ticket to accelerating their mission of advancing functional biology platforms and beefing up data partnerships. You know, the kind of partnerships that even the suits in...

Continue Reading
Skechers Facing Class Action: Investors Urged to Act

Updated Category News Views 0

Skechers Under Fire: Fraud Allegations Surface Alright, if you've been around the stock block a while, you know these stories can often read like a suspense novel. Plot twist: Skechers U.S.A., Inc. (formerly NYSE: SKX) is now facing some serious accusations. There's a class action lawsuit claiming that some shady dealings went down during the company's $9.4 billion...

Continue Reading
Cumberland Pharmaceuticals Eyes NDA for Ifetroban in DMD

Updated Category News Views 0

Rolling the Dice with Ifetroban There's a buzz in the air around Cumberland Pharmaceuticals as they gear up to tackle one of medicine's stubborn giants, Duchenne muscular dystrophy (DMD). They plan to file a New Drug Application (NDA) with the FDA for ifetroban, aiming to treat the cardiomyopathy plaguing many DMD sufferers. Folks who’ve watched Cumberland (NASDAQ:CPIX)...

Continue Reading
Ernesta Expands Southeast Reach with Atlanta Showroom

Updated Category News Views 85

Ernesta's Southeast Play: The Atlanta Showroom Here's something to turn heads in the world of custom home design—Ernesta has just set up shop in Atlanta, a move that speaks volumes about their ambitions in the Southeast market. This isn't just about selling a few more rugs; it's a calculated step into a region ripe with design potential and a hunger for bespoke home...

Continue Reading
Gildan Activewear Faces Major Class Action Lawsuit

Updated Category News Views 126

Investors Turn Against Gildan Activewear Ever see a freight train barreling down the track? That's what it feels like when a class action lawsuit rears its head against a behemoth like Gildan Activewear Inc. (NYSE: GIL). After years of allegedly pulling the wool over investors' eyes, those same investors are now being called to muster—their chance to lead a charge of...

Continue Reading
Bertram Capital Backs MCE's Expansive Growth Vision

Updated Category News Views 92

A Strategic Move for Bertram Capital Right on the heels of seasoned market moves, Bertram Capital has thrown its support behind Motion & Control Enterprises (MCE). This isn't just another portfolio addition; it's a calculated step into the complex world of industrial distribution, partnering with a company renowned for its prowess in engineered solutions. If you've ever...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover Opportunities at the 2026 China Clean Expo

Updated Category News Views 158

Welcome to the China Clean Expo 2026 The 27th China Clean Expo (CCE) is set to take place from March 31 to April 3, 2026, at the Shanghai New International Expo Center. This event, organized by IM Sinoexpo with support from notable associations, including ISSA, promises to be a hub for industry leaders, innovators, and solution providers in the cleaning sector. The...

Continue Reading
Magellan Health and Calm Health Collaboration Enhances Support

Updated Category News Views 372

Magellan Health Partners with Calm Health Magellan Health, Inc. is excited to announce a new partnership with Calm Health, aimed at providing improved mental health support for its members. This collaboration is designed to streamline the process for individuals seeking help, ensuring they receive the necessary resources in a timely manner. Understanding the Importance of...

Continue Reading
Celebrating the Visionaries: 2025 Franklin Institute Laureates

Updated Category News Views 3874

Honoring Global Innovators Across Science and Business The Franklin Institute is set to celebrate the exceptional contributions of its 2025 Franklin Institute Laureates. This illustrious occasion recognizes pioneers who have made significant advancements in science, technology, and business leadership. Among the nine distinguished honorees are trailblazers like Muyinatu...

Continue Reading
Origin Investments Launches Innovative 1031 Exchange Program

Updated Category News Views 267

Origin Investments Enters the 1031 Exchange Market Origin Investments has marked a significant milestone by completing its first acquisition under the newly established Origin Exchange program, which focuses on Delaware Statutory Trust (DST) investments. The company has acquired The Starling, a modern multifamily community featuring 300 recently developed units,...

Continue Reading
Tenaris Sees Growth Amid Challenges in Q2 2025 Financials

Updated Category News Views 263

Tenaris Reports Second Quarter Financial Results for 2025 Tenaris S.A. (NYSE: TS, BMV: TS.MX, Milan: TEN) has released its financial results for the second quarter of 2025, demonstrating resilience in a fluctuating market. Compared to the same period last year, there have been notable changes in performance metrics, illustrating both growth opportunities and challenges...

Continue Reading